vs
Alpha Cognition Inc.（ACOG）与AIM ImmunoTech Inc.（AIM）财务数据对比。点击上方公司名可切换其他公司
Alpha Cognition Inc.的季度营收约是AIM ImmunoTech Inc.的133.0倍（$2.8M vs $21.0K）。Alpha Cognition Inc.净利率更高（-245.5% vs -19881.0%，领先19635.5%）
AIM ImmunoTech是一家总部位于美国佛罗里达州奥卡拉的生物制药企业，前身是Hemispherx Biopharma，1990年成立，目前专注于研发用于治疗多种癌症、各类病毒感染以及免疫缺陷疾病的创新疗法。
ACOG vs AIM — 直观对比
营收规模更大
ACOG
是对方的133.0倍
$21.0K
净利率更高
ACOG
高出19635.5%
-19881.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $21.0K |
| 净利润 | $-6.9M | $-4.2M |
| 毛利率 | — | — |
| 营业利润率 | -283.7% | -14057.1% |
| 净利率 | -245.5% | -19881.0% |
| 营收同比 | — | -53.3% |
| 净利润同比 | — | 30.0% |
| 每股收益（稀释后） | $-0.10 | $-6.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACOGAIM
| Q4 25 | $2.8M | $21.0K | ||
| Q3 25 | $2.8M | $26.0K | ||
| Q2 25 | $1.7M | $25.0K | ||
| Q1 25 | $2.9M | $16.0K | ||
| Q4 24 | — | $45.0K | ||
| Q3 24 | — | $35.0K | ||
| Q2 24 | — | $50.0K | ||
| Q1 24 | — | $40.0K |
净利润ACOGAIM
| Q4 25 | $-6.9M | $-4.2M | ||
| Q3 25 | $-1.3M | $-3.3M | ||
| Q2 25 | $-10.5M | $-2.8M | ||
| Q1 25 | $-2.0M | $-3.7M | ||
| Q4 24 | — | $-6.0M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | — | $-1.8M | ||
| Q1 24 | — | $-5.8M |
毛利率ACOGAIM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 96.7% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ACOGAIM
| Q4 25 | -283.7% | -14057.1% | ||
| Q3 25 | -187.0% | -9411.5% | ||
| Q2 25 | -346.1% | -10584.0% | ||
| Q1 25 | -125.9% | -22618.8% | ||
| Q4 24 | — | -13011.1% | ||
| Q3 24 | — | -12825.7% | ||
| Q2 24 | — | -7388.0% | ||
| Q1 24 | — | -14335.0% |
净利率ACOGAIM
| Q4 25 | -245.5% | -19881.0% | ||
| Q3 25 | -46.4% | -12630.8% | ||
| Q2 25 | -632.7% | -11176.0% | ||
| Q1 25 | -68.5% | -23156.3% | ||
| Q4 24 | — | -13260.0% | ||
| Q3 24 | — | -10571.4% | ||
| Q2 24 | — | -3672.0% | ||
| Q1 24 | — | -14542.5% |
每股收益（稀释后）ACOGAIM
| Q4 25 | $-0.10 | $-6.46 | ||
| Q3 25 | $-0.30 | $1.57 | ||
| Q2 25 | $-0.65 | $-3.68 | ||
| Q1 25 | $-0.13 | $-0.05 | ||
| Q4 24 | — | $-21.80 | ||
| Q3 24 | — | $-6.00 | ||
| Q2 24 | — | $-3.00 | ||
| Q1 24 | — | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.0M | $3.0M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $62.5M | $-9.8M |
| 总资产 | $79.7M | $5.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACOGAIM
| Q4 25 | $66.0M | $3.0M | ||
| Q3 25 | $35.4M | $2.4M | ||
| Q2 25 | $39.4M | $835.0K | ||
| Q1 25 | $45.5M | $2.2M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $7.2M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $10.9M |
总债务ACOGAIM
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.7M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | — | $3.3M | ||
| Q2 24 | — | $3.3M | ||
| Q1 24 | — | $3.3M |
股东权益ACOGAIM
| Q4 25 | $62.5M | $-9.8M | ||
| Q3 25 | $33.9M | $-6.1M | ||
| Q2 25 | $31.9M | $-6.5M | ||
| Q1 25 | $40.8M | $-3.9M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $2.9M | ||
| Q2 24 | — | $6.1M | ||
| Q1 24 | — | $4.8M |
总资产ACOGAIM
| Q4 25 | $79.7M | $5.8M | ||
| Q3 25 | $46.3M | $5.5M | ||
| Q2 25 | $45.1M | $4.1M | ||
| Q1 25 | $48.6M | $6.2M | ||
| Q4 24 | — | $8.6M | ||
| Q3 24 | — | $13.6M | ||
| Q2 24 | — | $15.7M | ||
| Q1 24 | — | $16.2M |
负债/权益比ACOGAIM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.9M | $-2.0M |
| 自由现金流经营现金流 - 资本支出 | $-7.1M | — |
| 自由现金流率自由现金流/营收 | -252.6% | — |
| 资本支出强度资本支出/营收 | 5.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-20.7M | — |
8季度趋势，按日历期对齐
经营现金流ACOGAIM
| Q4 25 | $-6.9M | $-2.0M | ||
| Q3 25 | $-5.3M | $-5.1M | ||
| Q2 25 | $-6.1M | $-1.5M | ||
| Q1 25 | $-2.0M | $-2.4M | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $-3.1M | ||
| Q2 24 | — | $-3.0M | ||
| Q1 24 | — | $-4.8M |
自由现金流ACOGAIM
| Q4 25 | $-7.1M | — | ||
| Q3 25 | $-5.4M | — | ||
| Q2 25 | $-6.1M | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ACOGAIM
| Q4 25 | -252.6% | — | ||
| Q3 25 | -188.8% | — | ||
| Q2 25 | -370.9% | — | ||
| Q1 25 | -72.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ACOGAIM
| Q4 25 | 5.3% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
